| 251 |
TCPOBOP
|
|
107: Constitutive androstane receptor activation leading to hepatocellular adenomas and carcinomas in the mouse and the rat
|
| 286 |
Tebuconazole
|
-
Tebuconazole, CAS-RN: 107534-96-3, DTXSID9032113
|
None
|
| 164 |
Tebufenozide
|
-
Tebufenozide, CAS-RN: 112410-23-8, DTXSID4034948
|
2 AOPs
|
| 852 |
Tebufenpyrad
|
-
Tebufenpyrad, CAS-RN: 119168-77-3, DTXSID0034223
|
3: Inhibition of the mitochondrial complex I of nigro-striatal neurons leads to parkinsonian motor deficits
|
| 827 |
Technical chlordane
|
-
Technical chlordane, CAS-RN: 12789-03-6, DTXSID5023954
|
561: Aromatase induction leading to estrogen receptor alpha activation via increased estradiol
|
| 370 |
Teflubenzuron
|
-
Teflubenzuron, CAS-RN: 83121-18-0, DTXSID6042440
|
None
|
| 187 |
Telmisartan
|
-
Telmisartan, CAS-RN: 144701-48-4, DTXSID8023636
|
None
|
| 141 |
Tembotrione
|
-
Tembotrione, CAS-RN: 335104-84-2, DTXSID5047037
|
None
|
| 449 |
Temozolomide
|
-
Temozolomide, CAS-RN: 85622-93-1, DTXSID5043714
|
2 AOPs
|
| 322 |
Tenofovir
|
-
Tenofovir, CAS-RN: 147127-20-6, DTXSID9040132
|
256: Inhibition of mitochondrial DNA polymerase gamma leading to kidney toxicity
|
| 323 |
Tenofovir disoproxil fumarate
|
-
Tenofovir disoproxil fumarate, CAS-RN: 202138-50-9, DTXSID5050426
|
256: Inhibition of mitochondrial DNA polymerase gamma leading to kidney toxicity
|
| 706 |
Terfenadine
|
-
Terfenadine, CAS-RN: 50679-08-8, DTXSID2023642
|
2 AOPs
|
| 457 |
tert-Butyl hydroperoxide
|
-
tert-Butyl hydroperoxide, CAS-RN: 75-91-2, DTXSID9024693
|
296: Oxidative DNA damage leading to chromosomal aberrations and mutations
|
| 524 |
testJF
|
|
None
|
| 525 |
testJF2
|
|
None
|
| 708 |
Tetraarsenic trioxide
|
-
Tetraarsenic trioxide, CAS-RN: 83527-54-2, DTXSID80232428
|
None
|
| 261 |
Tetrabromobisphenol A
|
-
3,3',5,5'-Tetrabromobisphenol A, CAS-RN: 79-94-7, DTXSID1026081
|
2 AOPs
|
| 781 |
Tetrabromobisphenol A bis(2-hydroxyethyl) ether
|
-
Tetrabromobisphenol A bis(2-hydroxyethyl) ether, CAS-RN: 4162-45-2, DTXSID4038922
|
None
|
| 792 |
Tetracaine
|
|
553: Inhibition of Voltage-gated sodium channels (Na⁺ channels) leading to heart failure
|
| 88 |
Tetraconazole
|
-
Tetraconazole, CAS-RN: 112281-77-3, DTXSID8034956
|
None
|
| 204 |
Tetrahydrocannabinol
|
-
1-trans-delta-9-Tetrahydrocannabinol, CAS-RN: 1972-08-3, DTXSID6021327
|
None
|
| 94 |
Tetrodotoxin
|
|
553: Inhibition of Voltage-gated sodium channels (Na⁺ channels) leading to heart failure
|
| 794 |
Tetrodotoxin derivatives
|
|
553: Inhibition of Voltage-gated sodium channels (Na⁺ channels) leading to heart failure
|
| 806 |
Thapsigargin
|
|
556: Decreased Na/K ATPase activity leading to heart failure
|
| 798 |
Theophylline
|
|
554: β-adrenergic receptor agonists leading to arrhythmias.
|